Bhandari, J., Mah, J., Daya, R., Johnson, R. L., & Mishra, R. K. (2013). Compound 186 is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy. The Meducator, 1(22). https://doi.org/10.15173/m.v1i22.818